SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-017155
Filing Date
2024-02-20
Accepted
2024-02-20 16:29:38
Documents
12
Period of Report
2024-02-20
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K rapt-20240220.htm   iXBRL 8-K 35098
  Complete submission text file 0000950170-24-017155.txt   151524

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rapt-20240220.xsd EX-101.SCH 25973
13 EXTRACTED XBRL INSTANCE DOCUMENT rapt-20240220_htm.xml XML 4941
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38997 | Film No.: 24653900
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)